secwatch.observer — SEC 8-K summary
======================================

Issuer:     Coherus Oncology, Inc. (CHRS)
CIK:        0001512762
Form:       8-K
Filed at:   2024-12-04T23:59:59+00:00
Accession:  0001558370-24-016012
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Director Kimberly J. Tzoumakas resigns from Coherus board effective Dec 31, 2024
--------------------------------------------------------------------------------

- Kimberly J. Tzoumakas resigned from Coherus BioSciences Board, effective December 31, 2024.
- Resignation was not due to any disagreement with the Company's operations, policies, or practices.
- No replacement director has been announced as of the filing date.
- The Company thanked Ms. Tzoumakas for her contributions during her tenure.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024016012/0001558370-24-016012-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1512762/000155837024016012/chrs-20241127x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-24-016012

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer